A Prospective, Open-Label Study to Assess the Efficacy and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Subjects With Stage 1 and Stage 2 Hypertension
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Amlodipine; Olmesartan medoxomil
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 25 Sep 2009 Actual patient number (85) added as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2008 The expected completion date for this trial is now 1 Apr 2008, as reported by clinicaltrials.gov.